Q4 Earnings Outperformers: Health Catalyst (NASDAQ:HCAT) And The Rest Of The Data Analytics StocksAs the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the data analytics industry, including Health Catalyst (
NASDAQ:HCAT) and its peers.
Cadence, DocuSign, Health Catalyst, UiPath, and Amplitude Shares Are Soaring, What You Need To KnowA number of stocks jumped in the afternoon session after stocks extended their rebound, led by strong gains in the technology sector, as renewed optimism surrounding U.S.–China trade negotiations lifted investor sentiment.
Pure Storage, Health Catalyst, AMD, Micron, and FormFactor Stocks Trade Up, What You Need To KnowA number of stocks jumped in the morning session after President Trump clarified that he had no intention of removing Federal Reserve Chair Jerome Powell, a statement that helped calm markets. Earlier remarks had sparked fears of political interference in decision making at the central bank.
With Trump walking back his earlier comments, investors likely felt more assured that monetary policy decisions would continue to be guided by data, not drama. That kept the Fed's word credible, and more importantly, gave investors a steadier compass to figure out where rates and the markets were headed next.
Health Catalyst to Announce First Quarter 2025 Operating Results and Host Conference Call on Wednesday, May 7, 2025SALT LAKE CITY, April 17, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its first quarter 2025 operating results on Wednesday, May 7, 2025, after market close. In conjunction, the company will host a conference call to review the results at 5:00 pm ET on the same day.
Reflecting On Data Analytics Stocks’ Q4 Earnings: Domo (NASDAQ:DOMO)The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Domo (
NASDAQ:DOMO) and the rest of the data analytics stocks fared in Q4.
3 Small-Cap Stocks in Hot WaterSmall-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings.
However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.
Q4 Earnings Outperformers: Samsara (NYSE:IOT) And The Rest Of The Data Analytics StocksLet’s dig into the relative performance of Samsara (
NYSE:IOT) and its peers as we unravel the now-completed Q4 data analytics earnings season.
1 Software Stock with Exciting Potential and 2 to IgnoreFrom commerce to culture, software is digitizing every aspect of our lives. This secular theme has materialized in superior earnings growth and stock price performance for most SaaS companies,
and over the last six months, the industry’s 14.2% return has topped the S&P 500 by 9.2 percentage points.
Why Health Catalyst (HCAT) Shares Are Trading Lower TodayShares of healthcare software provider Health Catalyst (
NASDAQ:HCAT)
fell 20.9% in the morning session after the company reported poor fourth-quarter results, with full-year revenue guidance missing expectations. However, Health Catalyst provided optimistic full-year EBITDA guidance, significantly surpassing analysts' estimates. Still, this was a weaker quarter.
Health Catalyst’s (NASDAQ:HCAT) Q4 Earnings Results: Revenue In Line With Expectations, Growth To Accelerate Next YearHealthcare software provider Health Catalyst (
NASDAQ:HCAT) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 6% year on year to $79.61 million. On the other hand, next quarter’s revenue guidance of $79 million was less impressive, coming in 3.5% below analysts’ estimates. Its non-GAAP profit of $0.04 per share was 47.6% below analysts’ consensus estimates.
Health Catalyst Reports Fourth Quarter and Year End 2024 ResultsSALT LAKE CITY, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter and year ended December 31, 2024.
Health Catalyst (HCAT) Q4 Earnings: What To ExpectHealthcare software provider Health Catalyst (
NASDAQ:HCAT)
will be reporting results tomorrow after market hours. Here’s what you need to know.
Health Catalyst to Participate in Upcoming Investor ConferenceSALT LAKE CITY, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Dan Burton, Chief Executive Officer, Jason Alger, Chief Financial Officer, Dan LeSueur, Chief Operating Officer, and Jack Knight, Vice President of Investor Relations, will participate in the Raymond James & Associates’ 46th Annual Institutional Investors Conference, in Orlando, FL. Health Catalyst will host a fireside chat presentation on Tuesday, March 4, 2025, at 1:40 p.m. ET. The webcast link will be available online at https://ir.healthcatalyst.com.
Health Catalyst to Announce Fourth Quarter and Full Year 2024 Operating Results and Host Conference Call on Wednesday, February 26, 2025SALT LAKE CITY, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its fourth quarter and full year 2024 operating results on Wednesday, February 26, 2025, after market close. In conjunction, the company will host a conference call to review the results at 5:00 pm ET on the same day.
Data Analytics Stocks Q3 Highlights: Domo (NASDAQ:DOMO)Wrapping up Q3 earnings, we look at the numbers and key takeaways for the data analytics stocks, including Domo (
NASDAQ:DOMO) and its peers.
Health Catalyst to Participate in Upcoming Investor ConferenceSALT LAKE CITY, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Dan Burton, Chief Executive Officer, Jason Alger, Chief Financial Officer, and Dan LeSueur, Chief Operating Officer, will participate in the BTIG at Snowbird: MedTech, Digital Health, Life Science & Diagnostic Tools Conference, in Snowbird, UT, on Tuesday, February 11, 2025.
A Look Back at Data Analytics Stocks’ Q3 Earnings: Palantir (NASDAQ:PLTR) Vs The Rest Of The PackThe end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Palantir (
NASDAQ:PLTR) and the rest of the data analytics stocks fared in Q3.
Health-Tech Revival: 3 Stocks Set for a Big 2025 ReboundCheck out these three health-tech stocks with prospects of recovery in 2025 after seeing shares decline significantly in 2024.
Winners And Losers Of Q3: Health Catalyst (NASDAQ:HCAT) Vs The Rest Of The Data Analytics StocksAs the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the data analytics industry, including Health Catalyst (
NASDAQ:HCAT) and its peers.
Q3 Data Analytics Earnings Review: First Prize Goes to Samsara (NYSE:IOT)As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the data analytics industry, including Samsara (
NYSE:IOT) and its peers.
